SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 134 filers reported holding SAGE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,333,000 | +148.2% | 46,172 | +382.4% | 0.16% | +144.8% |
| Q3 2019 | $1,343,000 | -27.8% | 9,571 | -27.3% | 0.07% | -21.2% |
| Q3 2018 | $1,860,000 | -24.1% | 13,171 | -16.0% | 0.08% | -15.0% |
| Q2 2018 | $2,452,000 | +16.5% | 15,671 | -53.6% | 0.10% | -6.5% |
| Q3 2017 | $2,105,000 | +6.8% | 33,800 | +25.1% | 0.11% | +62.1% |
| Q2 2015 | $1,971,000 | +215.4% | 27,009 | +58.0% | 0.07% | +187.0% |
| Q4 2014 | $625,000 | – | 17,089 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |